Recurrence of nasopharyngeal carcinoma in the cavernous sinus

The arrival of ZAP-X in the world of radiosurgery has led to major advances in the treatment of diseases of the head, neck, and brain. At IRCA, we combine this innovative technology with a prestigious medical team to achieve the best treatments for our patients. We are therefore proud to have achieved great results during this time. Today we would like to tell you some details about how we treated a recurrence of nasopharyngeal carcinoma in the cavernous sinus.
After feeling discomfort in the nasal area, the patient, a 51-year-old man, came to the clinic for an initial assessment. The diagnosis was nasopharyngeal carcinoma, a malignant tumor formed from the epithelial tissue of the organs. In this case, another factor that led him to seek medical attention was a palpation of the lymph nodes, which revealed a left cervical adenopathy.
He therefore received a combination of radiotherapy and chemotherapy for this diagnosis, with an initial complete response.
Two years after the initial diagnosis, the patient presented symptoms of paralysis of his left eyelid and underwent an MRI scan of the skull, which revealed a 3 cm lesion in the left cavernous sinus. This finding was considered consistent with a local recurrence of the first tumor.

Treatment of recurrent nasopharyngeal carcinoma in the cavernous sinus with ZAP-X

Following this second diagnosis, the patient came to our center, where IRCA proposed a fully personalized treatment plan consisting of re-irradiation using radiosurgery in five sessions. This treatment was carried out in combination with concomitant hyperthermia.

Six months after placing himself in the hands of the IRCA medical team and following personalized treatment, the patient showed improvement in eyelid mobility and complete disappearance of the lesion.

One of the peculiarities of treating recurrences is that, in many cases, when the tumor reappears, it is not possible to continue emitting the same amount of radiation as on previous occasions. For this reason, ZAP-X achieves great results in these cases, as it allows for precise irradiation and optimization of each dose administered. This, combined with the fact that it is a completely non-invasive treatment, also allows for a quick recovery for the patient in general.

IRCA specializes in the radiosurgical treatment of functional or neurovascular diseases, as well as benign or malignant tumors in the head, neck, and brain. If you need our help, you can contact us by phone at 911 091 946 or by email at cfernandez@institutorca.com.